Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Obesity Clinical Trials

A listing of Obesity medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (11) clinical trials

Follow-Up of Fitness in Overweight Patients Treated With Physical Activity

Sedentarity is a risk factor for overweight, insulin resistance and diabetes mellitus. Several randomized clinical trials have shown that lifestyle interventions including exercise are efficient in improving metabolic homeostasis in overweight and obese patients. This may be related sedentarity being associated with low physical fitness, and to training enhancing it ...

Phase N/A

Time Restricted Feeding on Weight Loss and Cardio-protection (TREATY Trial)

Time restricted feeding (TRF) is a novel type of intermittent calorie restriction diet that involves eating a daily period of 8 hours or less. This is a randomized controlled trial to evaluate the effect of time restricted feeding (TRF) on weight loss and cardiometabolic risk factors in obese adults over ...

Phase N/A

Evaluation of Food Additive Contributions to Obesity - Feasibility Study 1

The effects of food additives on body weight in humans are largely unknown. This is a before-and-after feasibility study in 5 obese adults who will be followed for 5 months. Eligible participants will meet with the study team and will be taught how to limit the exposure to the studied ...

Phase N/A

Evaluation of Food Additive Contributions to Obesity - Feasibility Study 2

The effects of food additives on body weight in humans are largely unknown. This is a before-and-after feasibility study in 5 obese adults who will be followed for 5 months. Eligible participants with meet with the study team and will be taught how to limit the exposure to the studied ...

Phase N/A

Establishment of a Database of Patients Suffering From Obesity With a Medical Treatment

Obesity is a public health problem, given its prevalence (15% in France in 2012, Obpi survey) but also by the complications that it generates. We were firstly, intersted in bone mineral density during obesity. We were able to confirm in an observational study that BMD (Z-score)was augmented. We also showed, ...

Phase N/A

Grape Polyphenols and Second-meal Effect

Twenty-five subjects with obesity will be were recruited. Detailed inclusion and exclusion criteria are provided below. The subjects will receive, after overnight fasting, either a monodose of freeze-dried grapes (equivalent to 300 g of fresh grapes) or isocaloric placebo solved in water, together with a high-fat breakfast. Blood samples will ...

Phase N/A

Smartphone Pedometers and Body Mass of Overweight and Obese Clients.

3.1 Study Area The Hospital is a melting pot of referral cases, fresh cases, executive patients and the masses alike and therefore gives a scout picture of the non-communicable diseases situation in Nigeria. First contact to undifferentiated patients is offered in the clinic. It is accredited by both the West ...

Phase N/A

Timing of Eating Study Among Obese Adults

The study consists of the following phases - screening, assessment visit 1, eating condition 1, assessment visit 2, a wash-out period, assessment visit 3, eating condition 2 and assessment visit 4, as discussed in detail below. The assessment visits will all consist of the same procedures and will take place ...

Phase N/A

Exercise and Diet Restriction on Cardiovascular Function in Obese Children and Adolescents

Sixty obese children and adolescents will complete a 6-week program of exercise and diet intervention. Thirty normal-weight children and adolescents will be recruited as control group. Clinical characteristics, body composition, blood biochemistry, and circulating irisin levels of the subjects will be measured before and after 6-week intervention. Endothelial function will ...

Phase N/A

Multiple Ascending Dose Study of AMG 598 in Subjects With Obesity

This is a randomized, double-blind, placebo-controlled, multiple ascending dose study in subjects with obesity. AMG 598 will be evaluated in approximately 108 subjects to assess safety, tolerability, pharmacokinetics and pharmacodynamic effects.

Phase